Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ACORYS MAPPING SYSTEM

K-Number: K253861 · 2026-04-13

Decision Date2026-04-13
Product CodeDQK
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

ACORYS MAPPING SYSTEM is a medical device manufactured by Corify Care S.L. It received FDA 510(k) clearance on 2026-04-13 under approval number K253861. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ACORYS MAPPING SYSTEM?

ACORYS MAPPING SYSTEM is a medical device that received FDA 510(k) clearance on 2026-04-13. It is manufactured by Corify Care S.L. The 510(k) number is K253861.

When was ACORYS MAPPING SYSTEM approved by the FDA?

ACORYS MAPPING SYSTEM received FDA 510(k) clearance on 2026-04-13, under approval number K253861.

What company makes ACORYS MAPPING SYSTEM?

ACORYS MAPPING SYSTEM is manufactured by Corify Care S.L.

What is the FDA product code for ACORYS MAPPING SYSTEM?

The FDA product code for ACORYS MAPPING SYSTEM is DQK.

Related Clinical Trials

Related Devices (Code: DQK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.